Search details
1.
PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer.
Mol Cell Proteomics
; 22(4): 100529, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36931626
2.
Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.
Gastroenterology
; 165(1): 104-120, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36933623
3.
EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc-initiated colonic tumorigenesis.
Development
; 148(12)2021 06 15.
Article
in English
| MEDLINE | ID: mdl-34180969
4.
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Gut
; 70(11): 2138-2149, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33414168
5.
Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
Mod Pathol
; 33(3): 483-495, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31471586
6.
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Mod Pathol
; 33(7): 1420-1432, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32047231
7.
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Gut
; 68(3): 465-474, 2019 03.
Article
in English
| MEDLINE | ID: mdl-29382774
8.
Somatic mutation footprinting reveals a unique tetranucleotide signature associated with intron-exon boundaries in lung cancer.
Carcinogenesis
; 39(2): 225-231, 2018 02 09.
Article
in English
| MEDLINE | ID: mdl-29206898
9.
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Gastroenterology
; 153(4): 1082-1095, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28625833
10.
Focusing the Spotlight on the Zebrafish Intestine to Illuminate Mechanisms of Colorectal Cancer.
Adv Exp Med Biol
; 916: 411-37, 2016.
Article
in English
| MEDLINE | ID: mdl-27165364
11.
Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
Genes Chromosomes Cancer
; 54(5): 303-14, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25726927
12.
FunRich: An open access standalone functional enrichment and interaction network analysis tool.
Proteomics
; 15(15): 2597-601, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25921073
13.
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Br J Cancer
; 113(6): 979-88, 2015 Sep 15.
Article
in English
| MEDLINE | ID: mdl-26305864
14.
Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
STAR Protoc
; 5(2): 103090, 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38809757
15.
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer.
Cell Death Dis
; 15(3): 183, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38429301
16.
Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.
Mol Cancer
; 12: 1, 2013 Jan 03.
Article
in English
| MEDLINE | ID: mdl-23286373
17.
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations.
Am J Gastroenterol
; 108(11): 1785-93, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-24042191
18.
Proteomic and electron microscopy survey of large assemblies in macrophage cytoplasm.
Mol Cell Proteomics
; 10(6): M111.008763, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21406389
19.
Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer.
Cell Rep Med
; 4(12): 101335, 2023 12 19.
Article
in English
| MEDLINE | ID: mdl-38118423
20.
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status.
J Mol Diagn
; 25(2): 94-109, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36396080